Reishi mushroom extract market forecast to reach $17.4 billion by 2033

By AI, Created 10:58 AM UTC, May 18, 2026, /AGP/ – Global demand for natural wellness products is pushing the reishi mushroom extract market toward $17.4 billion by 2033, according to a new industry forecast. Growth is tied to immune health supplements, functional foods and beverages, and broader interest in preventive healthcare.

Why it matters: - Reishi mushroom extract is moving from a niche herbal ingredient into mainstream nutraceuticals, functional foods, beverages and cosmetics. - The market’s projected rise to US$ 17.4 billion by 2033 signals continued consumer spending on natural immunity boosters and plant-based wellness products. - The forecast matters for supplement makers, ingredient suppliers and brands building around clean-label and preventive health positioning.

What happened: - The global reishi mushroom extract market is forecast to reach US$ 17.4 billion by 2033. - The market is expected to be worth US$ 7.5 billion in 2026. - The forecast implies a 10.0% compound annual growth rate from 2026 to 2033. - The outlook comes from a Persistence Market Research report released May 18, 2026.

The details: - Reishi mushroom extract comes from Ganoderma lucidum and is used for its anti-inflammatory, antioxidant and adaptogenic properties. - Demand is rising across dietary supplements, functional food, beverages, pharmaceuticals and cosmetic formulations. - The report points to growing concern over lifestyle-related diseases as a major demand driver. - Consumer interest in immune health supplements and plant-based bioactive ingredients is also supporting growth. - Scientific validation of medicinal mushroom benefits is expanding, which is strengthening market credibility. - North America currently leads the market, helped by strong supplement demand, high awareness of functional mushrooms and a growing nutraceutical sector. - Europe holds a substantial share, supported by demand for organic and plant-based supplements and favorable regulation. - Asia-Pacific is expected to be the fastest-growing region, with China, Japan and South Korea benefiting from long-standing medicinal mushroom use. - Latin America and the Middle East and Africa are seeing gradual adoption as wellness markets expand. - The market is segmented by form into powder and liquid. - The market is segmented by application into dietary supplements, functional food, beverages and pharmaceuticals. - The market is segmented by distribution channel into online stores and offline stores. - Modern dual extraction methods using water and alcohol are improving potency and bioavailability of polysaccharides and triterpenes. - Artificial intelligence and data analytics are being used to optimize supply chains, forecast demand and improve formulation efficiency. - IoT and 5G are emerging as tools for real-time monitoring of production quality, storage conditions and distribution. - Sustainability concerns are pushing more organic cultivation and environmentally responsible harvesting.

Between the lines: - The forecast reflects a broader shift in consumer health behavior toward preventive care instead of treatment after illness. - Reishi’s growth potential depends not only on wellness demand but also on standardization, regulation and evidence that can support broader adoption. - Technology is becoming a competitive advantage in a market that still relies on cultivation quality and extract consistency.

What’s next: - The report expects more use of reishi in pharmaceutical research, functional nutrition and personalized supplement products. - Better clinical validation could open new drug development and evidence-based nutraceutical opportunities. - Biotechnology and precision fermentation may improve yields and lower production costs. - Stricter dietary supplement rules are likely to push higher labeling transparency and quality standards. - Digital systems in manufacturing and distribution are expected to improve efficiency and market access.

The bottom line: - Reishi mushroom extract is evolving into a global wellness ingredient with strong growth potential, but scale will depend on proof, regulation and supply-chain execution.